In vitro evaluation of tigemonam, a novel oral monobactam.

Tigemonam, a novel, orally administered monobactam, exhibited potent and specific activity in vitro against members of the family Enterobacteriaceae, Haemophilus influenzae, and Neisseria gonorrhoeae. Its activity was variable to poor against gram-positive bacteria, Acinetobacter spp., Pseudomonas a...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Tanaka, S K, Summerill, R A, Minassian, B F, Bush, K, Visnic, D A, Bonner, D P, Sykes, R B
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1987
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174695/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3105448/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.2.219
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!